XML 81 R84.htm IDEA: XBRL DOCUMENT v3.2.0.727
Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
shares in Millions, $ in Millions
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 381.7 $ 447.5
Cash flows from investing activities:    
Capital expenditures (122.0) (153.3)
Cash paid for acquisitions, net 0.0 (33.0)
Proceeds from sale of property, plant and equipment 0.0 5.0
Purchase of marketable securities (51.6) (10.5)
Proceeds from sale of marketable securities 21.6 7.8
Investments in affiliates 0.0 0.0
Loans to affiliates 0.0 0.0
Repayments of loans from affiliates 0.0 0.0
Payments for product rights and other, net (115.8) (135.3)
Net cash used in investing activities (267.8) (319.3)
Cash flows from financing activities:    
Payment of financing fees (83.6) (2.6)
Change in short-term borrowings, net 105.6 (193.3)
Proceeds from convertible note hedge 667.9 0.0
Proceeds from issuance of long-term debt 305.0 240.0
Payment of long-term debt (973.6) (300.0)
Proceeds from exercise of stock options 86.4 29.9
Taxes paid related to net share settlement of equity awards (31.7) (22.8)
Capital contribution from affiliates 0.0 0.0
Payments on borrowings from affiliates 0.0 0.0
Proceeds from borrowings from affiliates 0.0 0.0
Acquisition of noncontrolling interest (10.6) 0.0
Other items, net 48.0 21.3
Net cash provided by (used in) financing activities 113.4 (227.5)
Effect of Exchange Rate on Cash and Cash Equivalents (13.1) 1.9
Net increase (decrease) in cash and cash equivalents 214.2 (97.4)
Cash and cash equivalents — beginning of period 225.5 291.3
Cash and cash equivalents — end of period $ 439.7 $ 193.9
Non-cash transaction:    
Ordinary shares issued for acquisition 6,305.8 0.0
Eliminations    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 0.0 $ 0.0
Cash flows from investing activities:    
Capital expenditures 0.0 0.0
Cash paid for acquisitions, net   0.0
Proceeds from sale of property, plant and equipment   0.0
Purchase of marketable securities 0.0 0.0
Proceeds from sale of marketable securities 0.0 0.0
Investments in affiliates 257.9 27.5
Loans to affiliates 6,063.3 4,335.3
Repayments of loans from affiliates (217.2) (8.4)
Payments for product rights and other, net 0.0 0.0
Net cash used in investing activities 6,104.0 4,354.4
Cash flows from financing activities:    
Payment of financing fees 0.0 0.0
Change in short-term borrowings, net 0.0 0.0
Proceeds from convertible note hedge 0.0  
Proceeds from issuance of long-term debt 0.0 0.0
Payment of long-term debt 0.0 0.0
Proceeds from exercise of stock options 0.0 0.0
Taxes paid related to net share settlement of equity awards 0.0 0.0
Capital contribution from affiliates (257.9) (27.5)
Payments on borrowings from affiliates 217.2 (4,335.3)
Proceeds from borrowings from affiliates (6,063.3) 8.4
Acquisition of noncontrolling interest 0.0  
Other items, net 0.0 0.0
Net cash provided by (used in) financing activities (6,104.0) (4,354.4)
Effect of Exchange Rate on Cash and Cash Equivalents 0.0 0.0
Net increase (decrease) in cash and cash equivalents 0.0 0.0
Cash and cash equivalents — beginning of period 0.0 0.0
Cash and cash equivalents — end of period $ 0.0 0.0
Non-cash transaction:    
Ordinary shares issued for acquisition 0.0  
Mylan N.V.    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 0.0  
Cash flows from investing activities:    
Capital expenditures 0.0  
Purchase of marketable securities 0.0  
Proceeds from sale of marketable securities 0.0  
Investments in affiliates 0.0  
Loans to affiliates (33.1)  
Repayments of loans from affiliates 0.0  
Payments for product rights and other, net 0.0  
Net cash used in investing activities (33.1)  
Cash flows from financing activities:    
Payment of financing fees (60.9)  
Change in short-term borrowings, net 0.0  
Proceeds from convertible note hedge 0.0  
Proceeds from issuance of long-term debt 0.0  
Payment of long-term debt 0.0  
Proceeds from exercise of stock options 33.1  
Taxes paid related to net share settlement of equity awards 0.0  
Capital contribution from affiliates 0.0  
Payments on borrowings from affiliates 0.0  
Proceeds from borrowings from affiliates 60.9  
Acquisition of noncontrolling interest 0.0  
Other items, net 0.0  
Net cash provided by (used in) financing activities 33.1  
Effect of Exchange Rate on Cash and Cash Equivalents 0.0  
Net increase (decrease) in cash and cash equivalents 0.0  
Cash and cash equivalents — beginning of period 0.1  
Cash and cash equivalents — end of period $ 0.1  
Non-cash transaction:    
Ordinary shares issued for acquisition 6,305.8  
Mylan Inc.    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ (726.2) (638.6)
Cash flows from investing activities:    
Capital expenditures (37.1) (44.7)
Cash paid for acquisitions, net   0.0
Proceeds from sale of property, plant and equipment   0.0
Purchase of marketable securities (28.9) (3.3)
Proceeds from sale of marketable securities 0.0 0.0
Investments in affiliates (257.9) (27.5)
Loans to affiliates (2,583.7) (1,793.9)
Repayments of loans from affiliates 196.4 3.2
Payments for product rights and other, net 0.0 0.0
Net cash used in investing activities (2,711.2) (1,866.2)
Cash flows from financing activities:    
Payment of financing fees (22.7) (2.6)
Change in short-term borrowings, net 0.0 0.0
Proceeds from convertible note hedge 667.9  
Proceeds from issuance of long-term debt 305.0 240.0
Payment of long-term debt (973.6) (300.0)
Proceeds from exercise of stock options 53.3 29.9
Taxes paid related to net share settlement of equity awards (25.8) (17.3)
Capital contribution from affiliates 0.0 0.0
Payments on borrowings from affiliates (20.8) 2,541.4
Proceeds from borrowings from affiliates 3,479.6 (5.2)
Acquisition of noncontrolling interest 0.0  
Other items, net 48.0 21.3
Net cash provided by (used in) financing activities 3,510.9 2,507.5
Effect of Exchange Rate on Cash and Cash Equivalents 0.0 0.0
Net increase (decrease) in cash and cash equivalents 73.5 2.7
Cash and cash equivalents — beginning of period 112.9 14.4
Cash and cash equivalents — end of period $ 186.4 17.1
Non-cash transaction:    
Ordinary shares issued for acquisition 0.0  
Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 0.0 0.0
Cash flows from investing activities:    
Capital expenditures 0.0 0.0
Cash paid for acquisitions, net   0.0
Proceeds from sale of property, plant and equipment   0.0
Purchase of marketable securities 0.0 0.0
Proceeds from sale of marketable securities 0.0 0.0
Investments in affiliates 0.0 0.0
Loans to affiliates 0.0 0.0
Repayments of loans from affiliates 0.0 0.0
Payments for product rights and other, net 0.0 0.0
Net cash used in investing activities 0.0 0.0
Cash flows from financing activities:    
Payment of financing fees 0.0 0.0
Change in short-term borrowings, net 0.0 0.0
Proceeds from convertible note hedge 0.0  
Proceeds from issuance of long-term debt 0.0 0.0
Payment of long-term debt 0.0 0.0
Proceeds from exercise of stock options 0.0 0.0
Taxes paid related to net share settlement of equity awards 0.0 0.0
Capital contribution from affiliates 0.0 0.0
Payments on borrowings from affiliates 0.0 0.0
Proceeds from borrowings from affiliates 0.0 0.0
Acquisition of noncontrolling interest 0.0  
Other items, net 0.0 0.0
Net cash provided by (used in) financing activities 0.0 0.0
Effect of Exchange Rate on Cash and Cash Equivalents 0.0 0.0
Net increase (decrease) in cash and cash equivalents 0.0 0.0
Cash and cash equivalents — beginning of period 0.0 0.0
Cash and cash equivalents — end of period $ 0.0 0.0
Non-cash transaction:    
Ordinary shares issued for acquisition 0.0  
Non-Guarantor Subsidiaries    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 1,107.9 1,086.1
Cash flows from investing activities:    
Capital expenditures (84.9) (108.6)
Cash paid for acquisitions, net   (33.0)
Proceeds from sale of property, plant and equipment   5.0
Purchase of marketable securities (22.7) (7.2)
Proceeds from sale of marketable securities 21.6 7.8
Investments in affiliates 0.0 0.0
Loans to affiliates (3,446.5) (2,541.4)
Repayments of loans from affiliates 20.8 5.2
Payments for product rights and other, net (115.8) (135.3)
Net cash used in investing activities (3,627.5) (2,807.5)
Cash flows from financing activities:    
Payment of financing fees 0.0 0.0
Change in short-term borrowings, net 105.6 (193.3)
Proceeds from convertible note hedge 0.0  
Proceeds from issuance of long-term debt 0.0 0.0
Payment of long-term debt 0.0 0.0
Proceeds from exercise of stock options 0.0 0.0
Taxes paid related to net share settlement of equity awards (5.9) (5.5)
Capital contribution from affiliates 257.9 27.5
Payments on borrowings from affiliates (196.4) 1,793.9
Proceeds from borrowings from affiliates 2,522.8 (3.2)
Acquisition of noncontrolling interest (10.6)  
Other items, net 0.0 0.0
Net cash provided by (used in) financing activities 2,673.4 1,619.4
Effect of Exchange Rate on Cash and Cash Equivalents (13.1) 1.9
Net increase (decrease) in cash and cash equivalents 140.7 (100.1)
Cash and cash equivalents — beginning of period 112.5 276.9
Cash and cash equivalents — end of period $ 253.2 $ 176.8
Non-cash transaction:    
Ordinary shares issued for acquisition 0.0